I-Corps graduate, Strella Biotechnology, featured in Washington Post story
A featured story on Katherine Sizov, founder of Strella Biotechnology, and how the company's sensors are reducing food waste and fighting climate change.
Penn launches $750M investment in science, engineering, and medicine
President Amy Gutmann has announced the launch of a $750 million investment.
Pennovation Works Celebrates Five Years
November 8, 2021 marked the fifth anniversary of Pennovation Works, Penn’s business incubator and laboratory space.
Celebrating five years of innovation, entrepreneurship, and creativity
Penn Today marks the anniversary of Pennovation Works with a look at the evolution of the site, its research and commercialization achievements, and a glimpse into the future.
After setbacks, cell therapy for glioblastoma moves onto new chapter
At Penn, a leader in GBM cellular therapies since the early days of this technology, a new CAR cell therapy could find its way into clinical trials by next year in collaboration with Tmunity.
NIH, FDA and 15 private organizations join forces to increase effective gene therapies for rare diseases
NIH, FDA, 10 pharmaceutical companies and five non-profit organizations have partnered to accelerate development of gene therapies for rare diseases.
Scout Bio raises $4.75M to advance gene therapy for pets
The company has now raised more than $35 million since its inception.
Three of the top 20 highest-valued Philadelphia area startups are Penn spinouts
The Philadelphia Business Journal recently ranked the 20 highest-valued startups in Greater Philadelphia.
Success stories in gene therapy
Scientific American recently featured four stories on advancements in gene therapy.
Novel gene therapy platform speeds search for ways to cure blindness
A newly developed single-cell RNA sequencing technique enables researchers to quickly identify an optimal vector for delivering therapeutic genetic material to treat vision disorders.